Five-day brain treatment matches six-week results for resistant depression

For roughly one in three people with depression, standard medications simply don't work. When antidepressants fail, many turn to transcranial magnetic stimulation—a therapy that uses magnetic pulses to gently activate specific brain regions. The catch: the traditional version demands a clinic visit every weekday for two months straight. That's 30 appointments. For people juggling jobs, caregiving, or just the fog of depression itself, it's often impossible to sustain.

A UCLA study just showed there might be a faster path. Researchers tested whether patients could get the same relief by doing five sessions per day for five consecutive days—essentially compressing a two-month commitment into one intense week. The results were striking: both approaches worked equally well, and some patients who felt nothing immediately saw dramatic improvements two to four weeks later.

The Accelerated Protocol

The study tracked 175 people with treatment-resistant depression. About three-quarters followed the standard schedule—one session daily, five days a week, for six weeks. The rest tried the compressed version, which UCLA calls "5×5." Both groups showed clear symptom reduction with no statistically significant difference in overall effectiveness.

This matters because access is everything. "For patients who can't commit to six weeks of clinic visits, we may be able to offer meaningful relief in less than one week," said Michael Apostol, the study's lead author. That's not a small thing. It's the difference between a treatment that's theoretically available and one that's actually doable.

Transcranial magnetic stimulation itself is well-established. Large clinical trials show it significantly reduces symptoms in 60 to 70% of treatment-resistant patients, with 25 to 35% achieving full remission. Most insurance covers it. What's new is the timeline—and the possibility that you don't need to restructure your entire life to access it.

The Waiting Game

One finding deserves special attention: some patients in the accelerated group felt almost nothing after their five days of treatment. But when researchers checked back two to four weeks later, those same people showed substantial improvement—depression scores dropped by an average of 36%.

This delayed response suggests the brain needs time to consolidate the magnetic stimulation's effects. It's a crucial insight because it means the absence of immediate relief doesn't signal failure. Dr. Andrew Leuchter, director of UCLA's TMS service, emphasized this directly: "Some patients need to wait a few days or weeks to see benefit. We encourage them not to give up too quickly if they don't feel better right away."

That reframing alone—knowing that a two-week lag might precede real improvement—could keep people in the game when they otherwise might have given up.

The researchers were careful to note limitations. This wasn't a randomized controlled trial, meaning participants weren't randomly assigned to treatment groups, and larger studies are needed to fully confirm the findings. The traditional six-week protocol still showed stronger results on some longer-term measures, suggesting it remains the more proven option for now.

But the door is opening. UCLA scientists are already testing accelerated TMS for obsessive-compulsive disorder and chronic pain, signaling a broader shift toward making brain-based therapies faster and more accessible. For people trapped between a medication that doesn't work and a treatment schedule that doesn't fit their life, that shift could be the difference between staying stuck and actually getting better.